nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—saliva—conduct disorder	0.0741	0.544	CbGeAlD
Disopyramide—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0488	0.0565	CbGpPWpGaD
Disopyramide—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0485	0.0561	CbGpPWpGaD
Disopyramide—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.0455	0.0527	CbGpPWpGaD
Disopyramide—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.0452	0.0523	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—GABRA2—conduct disorder	0.0287	0.0333	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—GABRA2—conduct disorder	0.0256	0.0297	CbGpPWpGaD
Disopyramide—SLC22A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0253	0.0293	CbGpPWpGaD
Disopyramide—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0236	0.0273	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—SLC6A4—conduct disorder	0.0212	0.0245	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—DRD4—conduct disorder	0.0199	0.023	CbGpPWpGaD
Disopyramide—CHRM1—Monoamine GPCRs—DRD4—conduct disorder	0.0168	0.0195	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.0168	0.0194	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.0166	0.0192	CbGpPWpGaD
Disopyramide—KCND2—brain—conduct disorder	0.0154	0.113	CbGeAlD
Disopyramide—CHRM1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0142	0.0164	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.0141	0.0163	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.014	0.0162	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—COMT—conduct disorder	0.0138	0.016	CbGpPWpGaD
Disopyramide—KCND3—Neuronal System—MAOA—conduct disorder	0.0137	0.0159	CbGpPWpGaD
Disopyramide—KCND3—brain—conduct disorder	0.0134	0.0982	CbGeAlD
Disopyramide—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0129	0.0149	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—COMT—conduct disorder	0.0123	0.0143	CbGpPWpGaD
Disopyramide—KCND2—Neuronal System—MAOA—conduct disorder	0.0122	0.0142	CbGpPWpGaD
Disopyramide—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.012	0.0139	CbGpPWpGaD
Disopyramide—CHRM1—Monoamine GPCRs—HTR2A—conduct disorder	0.011	0.0127	CbGpPWpGaD
Disopyramide—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.011	0.0127	CbGpPWpGaD
Disopyramide—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.0108	0.0126	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00989	0.0115	CbGpPWpGaD
Disopyramide—CHRM1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00924	0.0107	CbGpPWpGaD
Disopyramide—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00921	0.0107	CbGpPWpGaD
Disopyramide—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00912	0.0106	CbGpPWpGaD
Disopyramide—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00859	0.00995	CbGpPWpGaD
Disopyramide—SCN5A—brain—conduct disorder	0.00804	0.059	CbGeAlD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00772	0.00894	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.00746	0.00863	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00744	0.00862	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.00738	0.00855	CbGpPWpGaD
Disopyramide—CHRM1—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00722	0.00835	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0072	0.00834	CbGpPWpGaD
Disopyramide—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00719	0.00833	CbGpPWpGaD
Disopyramide—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.00712	0.00825	CbGpPWpGaD
Disopyramide—KCND2—Circadian rythm related genes—EP300—conduct disorder	0.00688	0.00796	CbGpPWpGaD
Disopyramide—CHRM2—brain—conduct disorder	0.00684	0.0502	CbGeAlD
Disopyramide—SLC22A1—brain—conduct disorder	0.00672	0.0493	CbGeAlD
Disopyramide—CHRM1—brain—conduct disorder	0.00623	0.0457	CbGeAlD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00607	0.00703	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00592	0.00685	CbGpPWpGaD
Disopyramide—CHRM3—brain—conduct disorder	0.00557	0.0409	CbGeAlD
Disopyramide—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.00552	0.00639	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0051	0.00591	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00497	0.00576	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00496	0.00574	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00491	0.00568	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.00486	0.00563	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.00482	0.00558	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—SLC6A4—conduct disorder	0.00422	0.00489	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—DRD4—conduct disorder	0.00397	0.00459	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00384	0.00445	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—CGA—conduct disorder	0.00379	0.00438	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.00377	0.00437	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.00374	0.00433	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00372	0.0043	CbGpPWpGaD
Disopyramide—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00369	0.00427	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00347	0.00401	CbGpPWpGaD
Disopyramide—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.00346	0.004	CbGpPWpGaD
Disopyramide—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00344	0.00398	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00325	0.00376	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00324	0.00375	CbGpPWpGaD
Disopyramide—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00322	0.00372	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00321	0.00371	CbGpPWpGaD
Disopyramide—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00318	0.00368	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00313	0.00362	CbGpPWpGaD
Disopyramide—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00297	0.00343	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—COMT—conduct disorder	0.00285	0.0033	CbGpPWpGaD
Disopyramide—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00283	0.00327	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00278	0.00322	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00278	0.00321	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00275	0.00318	CbGpPWpGaD
Disopyramide—CHRM1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00274	0.00318	CbGpPWpGaD
Disopyramide—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	0.00273	0.00317	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—COMT—conduct disorder	0.00266	0.00307	CbGpPWpGaD
Disopyramide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00264	0.00306	CbGpPWpGaD
Disopyramide—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00264	0.00305	CbGpPWpGaD
Disopyramide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00245	0.00284	CbGpPWpGaD
Disopyramide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00245	0.00283	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CGA—conduct disorder	0.00214	0.00248	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CGA—conduct disorder	0.00213	0.00247	CbGpPWpGaD
Disopyramide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00212	0.00245	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—DRD4—conduct disorder	0.00212	0.00245	CbGpPWpGaD
Disopyramide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00211	0.00245	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—DRD4—conduct disorder	0.00211	0.00245	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.00211	0.00245	CbGpPWpGaD
Disopyramide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00209	0.00242	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.00209	0.00242	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CGA—conduct disorder	0.00194	0.00225	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CGA—conduct disorder	0.00194	0.00224	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.00192	0.00222	CbGpPWpGaD
Disopyramide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00182	0.0021	CbGpPWpGaD
Disopyramide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00181	0.0021	CbGpPWpGaD
Disopyramide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00179	0.00208	CbGpPWpGaD
Disopyramide—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00166	0.00192	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CGA—conduct disorder	0.00159	0.00184	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CGA—conduct disorder	0.00148	0.00171	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00141	0.00163	CbGpPWpGaD
Disopyramide—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.0014	0.00162	CbGpPWpGaD
Disopyramide—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00139	0.00161	CbGpPWpGaD
Disopyramide—CHRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00138	0.0016	CbGpPWpGaD
Disopyramide—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	0.00138	0.0016	CbGpPWpGaD
Disopyramide—CHRM1—Circadian rythm related genes—EP300—conduct disorder	0.00137	0.00159	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CGA—conduct disorder	0.00137	0.00158	CbGpPWpGaD
Disopyramide—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	0.00137	0.00158	CbGpPWpGaD
Disopyramide—SCN5A—Developmental Biology—EP300—conduct disorder	0.00128	0.00148	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—DRD4—conduct disorder	0.0012	0.00139	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	0.00119	0.00138	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	0.00118	0.00137	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CGA—conduct disorder	0.00115	0.00133	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CGA—conduct disorder	0.00114	0.00132	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CGA—conduct disorder	0.00113	0.00131	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—DRD4—conduct disorder	0.00109	0.00126	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—DRD4—conduct disorder	0.00108	0.00126	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—DRD4—conduct disorder	0.00107	0.00124	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—WASF1—conduct disorder	0.00092	0.00106	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—WASF1—conduct disorder	0.000917	0.00106	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—WASF1—conduct disorder	0.000908	0.00105	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.000782	0.000905	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	0.000779	0.000902	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	0.000772	0.000893	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—COMT—conduct disorder	0.000717	0.000831	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—MAOA—conduct disorder	0.000712	0.000825	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—conduct disorder	0.00071	0.000822	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	0.000708	0.000819	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	0.000701	0.000811	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—COMT—conduct disorder	0.000669	0.000774	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—MAOA—conduct disorder	0.000664	0.000769	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DRD4—conduct disorder	0.000643	0.000744	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DRD4—conduct disorder	0.000641	0.000742	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DRD4—conduct disorder	0.000634	0.000735	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—COMT—conduct disorder	0.000618	0.000715	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—MAOA—conduct disorder	0.000613	0.00071	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CGA—conduct disorder	0.000535	0.000619	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—conduct disorder	0.000419	0.000486	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—conduct disorder	0.000418	0.000484	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—conduct disorder	0.000414	0.000479	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—EP300—conduct disorder	0.000308	0.000356	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—EP300—conduct disorder	0.000287	0.000332	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—EP300—conduct disorder	0.000265	0.000307	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—COMT—conduct disorder	0.000241	0.00028	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MAOA—conduct disorder	0.00024	0.000278	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EP300—conduct disorder	0.000222	0.000257	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EP300—conduct disorder	0.000221	0.000256	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EP300—conduct disorder	0.000219	0.000254	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—EP300—conduct disorder	0.000104	0.00012	CbGpPWpGaD
